Emilie Hachet

Title: Emilie Hachet: Innovator in Glucose-Sensitive Hydrogels

Introduction

Emilie Hachet is a notable inventor based in La Roche-sur-Yon, France. She has made significant contributions to the field of biomedical engineering, particularly in the development of glucose-sensitive hydrogels. Her innovative work has the potential to impact diabetes management and drug delivery systems.

Latest Patents

Emilie Hachet holds a patent for a "Glucose responsive hydrogel comprising PBA-grafted hyaluronic acid (HA)." This polymer composition includes a mixture of PBA modified HA polymer grafted on at least a hydroxyl with a group comprising phenylboronic acid and Cis-diol modified HA polymer grafted on at least a hydroxyl with a group comprising a cis-diol. The invention focuses on injectable or implantable glucose-sensitive hydrogels that utilize this polymer composition. She has 1 patent to her name.

Career Highlights

Throughout her career, Emilie has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and Université Joseph Fourier - Grenoble 1. Her research has contributed to advancements in the understanding and application of hydrogels in medical settings.

Collaborations

Emilie has collaborated with notable colleagues, including Rachel Auzely-Velty and Bogdan Catargi. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.

Conclusion

Emilie Hachet is a pioneering inventor whose work in glucose-sensitive hydrogels showcases her commitment to advancing medical technology. Her contributions are poised to make a significant impact on healthcare solutions for diabetes management.